category
PNAS
date
Mar 19, 2026
slug
status
Published
summary
首次揭示转谷氨酰胺酶2(TG2)的交联活性是驱动α-突触核蛋白病理形成的核心机制,为突触核蛋白病(如帕金森病)提供了新的治疗靶点。
tags
蛋白质组学
type
Post

📄 原文题目

The cross-linking activity of transglutaminase 2 drives α-Synuclein pathology in synucleinopathy models

🔗 原文链接

💡 AI 核心解读

首次揭示转谷氨酰胺酶2(TG2)的交联活性是驱动α-突触核蛋白病理形成的核心机制,为突触核蛋白病(如帕金森病)提供了新的治疗靶点。

📝 英文原版摘要

Proceedings of the National Academy of Sciences, Volume 123, Issue 12, March 2026. <br />SignificanceTransglutaminase 2 (TG2) has been implicated in common neurodegenerative diseases and particularly in synucleinopathies that include Parkinson’s disease (PD) and dementia with Lewy bodies. However, due to its multidomain and multifunctional ...
SUN5形成规则蛋白晶格增强精子头尾连接处光感受器通过进化保守的分子通路调控多毛纲环节动物的生长和寿命
Loading...